Frontline treatment in multiple myeloma patients not eligible for stem-cell transplantation
Author:
Publisher
Elsevier BV
Subject
Clinical Biochemistry,Oncology
Reference43 articles.
1. A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Francais du Myelome;Attal;The New England Journal of Medicine,1996
2. Autologous stem-cell transplantation in elderly multiple myeloma patients over the age of 70 years;Badros;British Journal of Haematology,2001
3. High-dose melphalan (200 mg/m2) supported by autologous stem-cell transplantation is safe and effective in elderly (≥65 years) myeloma patients: comparison with younger patients treated on the same protocol;Jantunen;Bone Marrow Transplantation,2006
4. Treatment for multiple myeloma. Combination chemotherapy with different melphalan dose regimens;Alexanian;The Journal of the American Medical Association,1969
5. Multiple myeloma;Bataille;The New England Journal of Medicine,1997
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Evaluating results from the multiple myeloma patient subset treated with denosumab or zoledronic acid in a randomized phase 3 trial;Blood Cancer Journal;2016-01
2. A Phase IIb, Multicenter, Open-Label, Safety, and Efficacy Study of High-Dose, Propylene Glycol-Free Melphalan Hydrochloride for Injection (EVOMELA) for Myeloablative Conditioning in Multiple Myeloma Patients Undergoing Autologous Transplantation;Biology of Blood and Marrow Transplantation;2015-12
3. Multiple myeloma: chemotherapy or transplantation in the era of new drugs;European Journal of Haematology;2010-05
4. Meeting Highlights from: The 50th Annual Meeting of the American Society of Hematology; San Francisco, CA; December 6–9, 2008;Clinical Lymphoma and Myeloma;2009-04
5. Efficacy and safety of fotemustine for the treatment of relapsed and refractory multiple myeloma patients;European Journal of Haematology;2009-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3